Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/17/2026 | Q4 | $1.8B | -- | -- | $0.80 | -- |
| 10/29/2025 | Q3 | $1.9B | $1.9B | $0.90 | $1.03 | -$0.12 |
| 07/31/2025 | Q2 | $2B | $2.1B | $1.28 | $1.08 | $0.20 |
| 04/23/2025 | Q1 | $1.8B | $1.8B | $0.87 | $0.91 | -$0.04 |
| 02/11/2025 | Q4 | $1.8B | $1.8B | $0.85 | $0.87 | -$0.03 |
| 10/29/2024 | Q3 | $2B | $2B | $0.77 | $1.09 | -$0.32 |
| 07/25/2024 | Q2 | $2.1B | $2.1B | $1.17 | $1.18 | -$0.00 |
| 04/24/2024 | Q1 | $1.9B | $1.9B | $0.97 | $0.88 | $0.08 |
| 02/08/2024 | Q4 | $1.8B | $1.9B | $0.85 | $0.66 | $0.20 |
| 10/26/2023 | Q3 | $2B | $2B | $1.10 | $0.92 | $0.19 |
| 07/27/2023 | Q2 | -- | $2.1B | $1.16 | -- | -- |
| 04/26/2023 | Q1 | -- | $2B | $0.90 | -- | -- |
| 02/09/2023 | Q4 | -- | $1.9B | $0.50 | -- | -- |
| 10/26/2022 | Q3 | -- | $2.2B | $0.97 | -- | -- |
| 07/28/2022 | Q2 | -- | $2.4B | $1.18 | -- | -- |
| 04/27/2022 | Q1 | -- | $2.2B | $0.97 | -- | -- |
| 02/08/2022 | Q4 | -- | $2B | $0.55 | -- | -- |
| 10/27/2021 | Q3 | -- | $2.2B | $0.89 | -- | -- |
| 07/29/2021 | Q2 | -- | $2.2B | -$0.14 | -- | -- |
| 04/28/2021 | Q1 | -- | $2B | $0.34 | -- | -- |
| 02/09/2021 | Q4 | -- | $1.9B | $0.74 | -- | -- |
| 10/28/2020 | Q3 | -- | $2B | $1.05 | -- | -- |
| 07/30/2020 | Q2 | -- | $1.8B | $0.84 | -- | -- |
| 04/29/2020 | Q1 | -- | $1.6B | -$0.22 | -- | -- |
| 02/11/2020 | Q4 | -- | $1.6B | $0.30 | -- | -- |
| 10/30/2019 | Q3 | -- | $1.7B | $0.68 | -- | -- |
| 07/25/2019 | Q2 | -- | $1.8B | $0.82 | -- | -- |
| 04/25/2019 | Q1 | -- | $1.5B | $0.39 | -- | -- |
| 02/07/2019 | Q4 | -- | $911M | $0.64 | -- | -- |
| 10/30/2018 | Q3 | -- | $1.9B | $0.59 | -- | -- |
| 07/31/2018 | Q2 | -- | $2.3B | $0.68 | -- | -- |
| 04/24/2018 | Q1 | -- | $1.9B | $0.47 | -- | -- |
| 02/08/2018 | Q4 | -- | $1.9B | $0.28 | -- | -- |
| 10/24/2017 | Q3 | -- | $1.9B | $0.48 | -- | -- |
| 07/27/2017 | Q2 | -- | $2.1B | $0.50 | -- | -- |
| 04/25/2017 | Q1 | -- | $1.8B | $0.43 | -- | -- |
| 02/09/2017 | Q4 | -- | $1.8B | $0.30 | -- | -- |
| 10/25/2016 | Q3 | -- | $1.9B | $0.40 | -- | -- |
| 07/26/2016 | Q2 | -- | $2B | $0.45 | -- | -- |
| 04/26/2016 | Q1 | -- | $1.7B | $0.32 | -- | -- |
| 02/09/2016 | Q4 | -- | -- | -- | -- | -- |
Masco Corp. reported $1.9B worth of top line sales in its most recent quarter.
Masco Corp. announced earnings per share of $0.90 which represents a miss of analyst forecast a $1.03 per share.
Masco Corp. reported $656M that represents $3.14 per share over the last quarter.
Masco Corp.'s earnings are forecast to grow from $3.75 per share to $4.09 per share next year representing an increase of 4.93%.
Masco Corp.'s next earnings date is February 17, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.